Tiger Management Upped Its T2 Biosystems (TTOO) Holding by $1.31 Million; Ancora Advisors Raised Stake in Acco Brands Com (ACCO) as Stock Declined

May 22, 2018 - By Winifred Garcia

T2 Biosystems, Inc. (NASDAQ:TTOO) Logo

Ancora Advisors Llc increased its stake in Acco Brands Corp Com (ACCO) by 38.86% based on its latest 2017Q4 regulatory filing with the SEC. Ancora Advisors Llc bought 165,809 shares as the company’s stock declined 3.17% with the market. The hedge fund held 592,519 shares of the publishing company at the end of 2017Q4, valued at $7.23 million, up from 426,710 at the end of the previous reported quarter. Ancora Advisors Llc who had been investing in Acco Brands Corp Com for a number of months, seems to be bullish on the $1.37B market cap company. The stock increased 2.00% or $0.25 during the last trading session, reaching $12.75. About 592,568 shares traded or 11.41% up from the average. ACCO Brands Corporation (NYSE:ACCO) has declined 5.79% since May 22, 2017 and is downtrending. It has underperformed by 17.34% the S&P500.

Julian Robertson increased its stake in T2 Biosystems Inc (TTOO) by 16.4% based on its latest 2017Q4 regulatory filing with the SEC. Tiger Management Llc bought 327,115 shares as the company’s stock rose 47.17% while stock markets declined. The hedge fund run by Julian Robertson held 2.32 million shares of the health care company at the end of 2017Q4, valued at $9.57 million, up from 1.99M at the end of the previous reported quarter. Tiger Management Llc who had been investing in T2 Biosystems Inc for a number of months, seems to be bullish on the $307.25M market cap company. The stock increased 4.02% or $0.33 during the last trading session, reaching $8.53. About 762,476 shares traded or 110.11% up from the average. T2 Biosystems, Inc. (NASDAQ:TTOO) has risen 12.64% since May 22, 2017 and is uptrending. It has outperformed by 1.09% the S&P500.

Tiger Management Llc, which manages about $799.15M and $640.12 million US Long portfolio, decreased its stake in Norwegian Cruise Line Hldgs (NASDAQ:NCLH) by 28,900 shares to 219,000 shares, valued at $11.66 million in 2017Q4, according to the filing. It also reduced its holding in Alibaba Group Hldg Ltd (NYSE:BABA) by 166,900 shares in the quarter, leaving it with 22,700 shares, and cut its stake in Apollo Global Mgmt Llc (NYSE:APO).

More important recent T2 Biosystems, Inc. (NASDAQ:TTOO) news were published by: Schaeffersresearch.com which released: “2 Upgraded Drug Stocks Squeezing Shorts” on May 09, 2018, also Seekingalpha.com published article titled: “T2 Biosystems’ (TTOO) CEO John McDonough on Q1 2018 Results – Earnings Call Transcript”, Benzinga.com published: “36 Biggest Movers From Friday” on May 21, 2018. More interesting news about T2 Biosystems, Inc. (NASDAQ:TTOO) was released by: Globenewswire.com and their article: “T2 Biosystems Reports Granting of Inducement Awards” with publication date: May 03, 2018.

Among 9 analysts covering T2 Biosystems Inc (NASDAQ:TTOO), 6 have Buy rating, 1 Sell and 2 Hold. Therefore 67% are positive. T2 Biosystems Inc had 25 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Underweight” rating given on Wednesday, March 15 by Morgan Stanley. As per Monday, February 12, the company rating was maintained by H.C. Wainwright. The firm has “Neutral” rating given on Tuesday, July 21 by BTIG Research. H.C. Wainwright maintained it with “Buy” rating and $8.5000 target in Thursday, March 29 report. Canaccord Genuity initiated T2 Biosystems, Inc. (NASDAQ:TTOO) rating on Tuesday, October 27. Canaccord Genuity has “Buy” rating and $15 target. The rating was maintained by H.C. Wainwright on Wednesday, May 9 with “Buy”. The stock of T2 Biosystems, Inc. (NASDAQ:TTOO) earned “Buy” rating by Canaccord Genuity on Monday, October 30. The rating was downgraded by Janney Capital to “Neutral” on Tuesday, April 12. The stock of T2 Biosystems, Inc. (NASDAQ:TTOO) earned “Buy” rating by Canaccord Genuity on Wednesday, March 7. The company was maintained on Sunday, August 16 by BTIG Research.

More news for ACCO Brands Corporation (NYSE:ACCO) were recently published by: Streetinsider.com, which released: “ACCO Brands Corporation (ACCO) Declares $0.06 Quarterly Dividend; 2.1% Yield” on May 01, 2018. Globenewswire.com‘s article titled: “Report: Developing Opportunities within Crown, American Equity Investment Life Holding, Acco Brands, Synthetic …” and published on May 14, 2018 is yet another important article.

Among 4 analysts covering Acco Brands (NYSE:ACCO), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Acco Brands had 6 analyst reports since April 29, 2016 according to SRatingsIntel. The rating was maintained by Barrington Research with “Outperform” on Friday, April 29. BWS Financial initiated it with “Buy” rating and $18 target in Wednesday, January 25 report. The firm earned “Buy” rating on Friday, April 7 by BWS Financial. The rating was maintained by KeyBanc Capital Markets with “Hold” on Thursday, September 7. The company was maintained on Thursday, February 15 by Barrington.

T2 Biosystems, Inc. (NASDAQ:TTOO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Winifred Garcia

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: